Literature DB >> 54755

Matching quality of agents employed in "double-blind" controlled clinical trials.

L E Hill, A J Nunn, W Fox.   

Abstract

In an inquiry into the matching quality of preparations employed in double-blind controlled clinical trials, a panel of 4 observers studied 22 pairs of agents used in a sample of such trials, examining features which might make one preparation distinguishable from the other. 5 pairs of substances were an excellent match, being virtually indistinguishable, but in 7 pairs ther were obvious differences, detected by all 4 observers. The preparations used in cross-over studies were not specially well matched. Colour differences were most readily detected, followed by taste. The observers differed in their ability to detect differences between pairs of preparations, and 1 panel member was approximately 3 times more successful in doing so than another.

Mesh:

Substances:

Year:  1976        PMID: 54755     DOI: 10.1016/s0140-6736(76)90102-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  Assessing clinical trials- double-blind trials.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-11

2.  The placebo dilemma.

Authors:  L Schindel
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

Review 3.  The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials: a methodological systematic review.

Authors:  Segun Bello; Maoling Wei; Jørgen Hilden; Asbjørn Hróbjartsson
Journal:  BMC Med Res Methodol       Date:  2016-02-13       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.